Impact of diabetes on mortality in peripheral artery disease: a meta-analysis

Clinical Cardiology

Volumn 40, Issue 5, 2017, Pages 287-291

  Vrsalovic, Mislav ^a,b   Vucur, Ksenija ^c   Vrsalovic Presecki, Ana ^d   Fabijanic, Damir ^e   Milosevic, Milan ^a  

^a UNIVERSITY OF ZAGREB   (Croatia)

^b SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

^c University of Zagreb   (Croatia)

^d UNIVERSITY OF ZAGREB   (Croatia)

^e UNIVERSITY HOSPITAL SPLIT   (Croatia)

Author keywords

critical limb ischemia; diabetes; meta analysis; mortality; peripheral artery disease

Indexed keywords

ARTICLE; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CORONARY ARTERY DISEASE; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; FOLLOW UP; HUMAN; META ANALYSIS; MORTALITY RISK; NEWCASTLE-OTTAWA SCALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERAL VASCULAR DISEASE; SYSTEMATIC REVIEW; AGED; CRITICAL ILLNESS; FEMALE; ISCHEMIA; MALE; MIDDLE AGED; MORTALITY; ODDS RATIO; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CRITICAL ILLNESS; DIABETES MELLITUS; FEMALE; HUMANS; ISCHEMIA; MALE; MIDDLE AGED; ODDS RATIO; PERIPHERAL ARTERIAL DISEASE; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 85008441645     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22657     Document Type: Article

References (31)

1. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509–1526.
2. Creager MA, Lüscher TF, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I. Circulation. 2003;108:1527–1532.
3. Vrsalović M, Vučur K. Diabetes, renal dysfunction, inflammation, and anemia: the deadly quartet in peripheral artery disease. Endocr Oncol Metab. 2016;2:82–87.
4. Marso SP, Hiatt WR. Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006;47:921–929.
5. American Diabetes Association. Peripheral arterial disease in people with diabetes. Diabetes Care. 2003;26:3333–3341.
6. Abularrage CJ, Conrad MF, Hackney LA, et al. Long-term outcomes of diabetic patients undergoing endovascular infrainguinal interventions. J Vasc Surg. 2010;52:314–322.
7. Akbari CM, Pomposelli FB Jr, Gibbons GW, et al. Lower extremity revascularization in diabetes: late observations. Arch Surg. 2000;135:452–456.
8. Cheng SW, Ting AC, Lau H, et al. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg. 2000;14:158–165.
9. Collins TC, Beyth RJ, Nelson DB, et al. Process of care and outcomes in patients with peripheral arterial disease. J Gen Intern Med. 2007;22:942–948.
10. Dawson I, van Bockel JH, Brand R. Late nonfatal and fatal cardiac events after infrainguinal bypass for femoropopliteal occlusive disease during a thirty-one-year period. J Vasc Surg. 1993;18:249–260.
11. Dick F, Diehm N, Galimanis A, et al. Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg. 2007;45:751–761.
12. Garg PK, Tian L, Criqui MH, et al. Physical activity during daily life and mortality in patients with peripheral arterial disease. Circulation. 2006;114:242–248.
13. Golledge J, Quigley F, Velu R, et al. Association of impaired fasting glucose, diabetes and their management with the presentation and outcome of peripheral artery disease: a cohort study. Cardiovasc Diabetol. 2014;13:147.
14. Goodney PP, Nolan BW, Schanzer A, et al. Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg. 2010;51:71–78.
15. Jude EB, Oyibo SO, Chalmers N, et al. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diabetes Care. 2001;24:1433–1437.
16. Kalman PG, Johnston KW. Predictors of long-term patient survival after in situ vein leg bypass. J Vasc Surg. 1997;25:899–904.
17. Karacagil S, Almgren B, Bowald S, et al. Comparative analysis of patency, limb salvage and survival in diabetic and non-diabetic patients undergoing infrainguinal bypass surgery. Diabet Med. 1995;12:537–541.
18. Leibson CL, Ransom JE, Olson W, et al. Peripheral arterial disease, diabetes, and mortality. Diabetes Care. 2004;27:2843–2849.
19. Luther M, Lepäntalo M. Femorotibial reconstructions for chronic critical leg ischemia: influence on outcome by diabetes, gender and age. Eur J Vasc Endovasc Surg 1997;13:569–577.
20. Malmstedt J, Leander K, Wahlberg E, et al. Outcome after leg bypass surgery for critical limb ischemia is poor in patients with diabetes: a population-based cohort study. Diabetes Care. 2008;31:887–892.
21. Mueller T, Hinterreiter F, Luft C, et al. Mortality rates and mortality predictors in patients with symptomatic peripheral artery disease stratified according to age and diabetes. J Vasc Surg. 2014;59:1291–1299.
22. Missouris CG, Kalaitzidis RG, Kerry SM, et al. Predictors of mortality in patients with peripheral vascular disease: a prospective follow-up study. Br J Diabetes Vasc Dis. 2004;4:196–200.
23. Miura T, Soga Y, Miyashita Y, et al. Five-year prognosis after endovascular therapy in claudicant patients with iliofemoral artery disease. J Endovasc Ther. 2014;21:381–388.
24. Suzuki K, Iida O, Yamauchi Y, et al. Impact of diabetes mellitus on critical limb ischemia with below the knee disease: Japan below-the-knee artery treatment subanalysis [published online August 21, 2013]. Angiology. doi: 10.1177/0003319713499606.
25. Vrsalović M, Vučur K. Diabetes and critical limb ischemia: the deadly duo in patients with symptomatic peripheral artery disease. Acta Clin Croat. 2016;55:240–246.
26. Wölfle KD, Bruijnen H, Loeprecht H, et al. Graft patency and clinical outcome of femorodistal arterial reconstruction in diabetic and non-diabetic patients: results of a multicenter comparative analysis. Eur J Vasc Endovasc Surg. 2003;25:229–234.
27. Lee WL, Cheung AM, Cape D, et al. Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies. Diabetes Care. 2000;23:962–968.
28. Shou J, Zhou L, Zhu S, et al. Diabetes is an independent risk factor for stroke recurrence in stroke patients: a meta-analysis. J Stroke Cerebrovasc Dis. 2015;24:1961–1968.
29. Vrsalović M, Vučur K, Car B, et al. C-reactive protein, renal function, and cardiovascular outcome in patients with symptomatic peripheral artery disease and preserved left ventricular systolic function. Croat Med J. 2015;56:351–356.
30. Vrsalovic M, Vucur K, Jelakovic B. Atrial fibrillation predicts cardiovascular outcome in hypertensive patients with symptomatic peripheral artery disease and preserved ejection fraction. J Clin Hypertens (Greenwich). 2016;18:953–954.
31. Beckman JA, Paneni F, Cosentino F, et al. Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II. Eur Heart J. 2013;34:2444–2452.